Class Action Lawsuit News

Stay updated on class action lawsuits with press releases highlighting legal news, trends, and developments shaping collective legal actions. Explore opportunities in litigation, legal advocacy, and public interest law.

Apr 17, 2026 at 8:00 PM

SMPL INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving The Simply Good Foods Company

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of The Simply Good Foods Company (“Simply Good Foods” or the “Company”) (NASDAQ:SMPL) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 9, 2026, Simply Good Foods reported its financial results and updated its outlook. Am...
Apr 17, 2026 at 8:00 PM

OMF INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving OneMain Holdings, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of OneMain Holdings, Inc. (“OneMain” or the “Company”) (NYSE:OMF) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 16, 2026, New York Attorney General Letitia James, along with a coalition of 12 other state attorney gene...
Apr 17, 2026 at 7:05 PM

Rosen Law Firm Encourages Phreesia, Inc. Investors to Inquire About Securities Class Action Investigation – PHR

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Phreesia, Inc. (NYSE: PHR) resulting from allegations that Phreesia may have issued materially misleading business information to the investing public. So What: If you purchased Phreesia securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The R...
Apr 17, 2026 at 6:17 PM

Trade Desk Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Trade Desk, Inc. - TTD

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Trade Desk, Inc. (“Trade Desk” or the “Company”) (NasdaqGM: TTD). On February 12, 2025, the Company announced its financial results for the fourth quarter and full year of 2024, disclosing 4Q 2024 revenue of $741 million - below its previously issued guidance of $756...
Apr 17, 2026 at 6:13 PM

Fortinet Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortinet Inc. - FTNT

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Fortinet Inc. (the “Company”) (NasdaqGS: FTNT). On August 6, 2025, the Company disclosed disappointing second-quarter 2025 financial results, including that it was already “approximately 40% to 50% of the way through the 2026 upgrade cycle at the end of the second qu...
Apr 17, 2026 at 6:11 PM

Corcept 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics Incorporated (NasdaqCM: CORT) (“Corcept” or the “Company”), if they purchased or otherwise acquired the Company’s shares between October 31, 2024 and December 30, 2025, inclusive (the “Cl...
Apr 17, 2026 at 6:09 PM

Enphase Energy 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Enphase Energy, Inc. - ENPH

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Enphase Energy, Inc. (“Enphase” or the “Company”) (NasdaqGM: ENPH), if they purchased or otherwise acquired the Company’s shares between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”...
Apr 17, 2026 at 6:00 PM

EQPT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving EquipmentShare, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of EquipmentShare, Inc. (“EquipmentShare” or the “Company”) (NASDAQ:EQPT) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 18, 2026, after the market closed, EquipmentShare reported financial results that revealed the ma...
Apr 17, 2026 at 5:35 PM

REMINDER: Atara Biotherapeutics, Inc. Investors With Significant Losses Must Act By May 22, 2026 – Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ:ATRA) investors of the May 22, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors a...
Apr 17, 2026 at 5:23 PM

Rosen Law Firm Encourages Propanc Biopharma Inc. Investors to Inquire About Securities Class Action Investigation – PPCB

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Propanc Biopharma Inc. (NASDAQ: PPCB) resulting from allegations that Propanc may have issued materially misleading business information to the investing public. So what: If you purchased Propanc securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangeme...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up